Cargando…

The BC Cancer Agency Compassionate Access Program: outcome analysis of patients with esophagogastric cancer

BACKGROUND: The BC Cancer Agency Gastro-intestinal Tumor Group supports one standard of care (soc) chemotherapy regimen for metastatic esophagogastric adenocarcinoma—specifically, weekly cisplatin and 5-fluorouracil (5fu) infusion. All other regimens require Compassionate Access Program (cap) approv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, K.S., Barnett, J.B., Shah, A., Khoo, K.E.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2009
Materias:	Medical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768501/ https://www.ncbi.nlm.nih.gov/pubmed/19862357

Ejemplares similares

Targeting EGFR in Esophagogastric Cancer
por: Maron, Steven B., et al.
Publicado: (2020)

Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors
por: Kennedy, Susan A., et al.
Publicado: (2021)

Impact of Age on the Treatment and Survival in Esophagogastric Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2023)

Characterizing expanded access and compassionate use programs for experimental drugs
por: Miller, Jennifer E., et al.
Publicado: (2017)

Cultivating a Therapeutic Compassionate Relationship: The 3S Approach
por: Samoutis, George, et al.
Publicado: (2019)

Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Arterial Infusion Chemotherapy for Neoplastic Esophagogastric Anastomotic Strictures After Esophagectomy
por: Xie, Pengfei, et al.
Publicado: (2021)

The Role of Elongin BC-Containing Ubiquitin Ligases
por: Okumura, Fumihiko, et al.
Publicado: (2012)

Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction
por: Xiong, Jianping, et al.
Publicado: (2020)

Anemia is a common but neglected complication of adjuvant chemotherapy for early breast cancer
por: Goldrick, A., et al.
Publicado: (2007)

Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience
por: Lin, Li-Ching, et al.
Publicado: (2022)

Compassionate Coverage: A Patient Access Linen System
por: Rabin, Jill Maura, et al.
Publicado: (2018)

An approach to data collection in compassionate use/managed access
por: Sarp, Séverine, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma
por: Wang, Ying, et al.
Publicado: (2021)

Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices
por: Tao, Ziwen, et al.
Publicado: (2021)

Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
por: Lin, Li-Ching, et al.
Publicado: (2022)

Compassionate use programs in Italy: ethical guidelines
por: De Panfilis, Ludovica, et al.
Publicado: (2018)

Development of a breast cancer case management information platform (BC-CMIP) module based on patient-perceived value
por: Liang, Yinyin, et al.
Publicado: (2022)

Cancer-associated thrombosis: prevention and treatment
por: Brose, K.M.J., et al.
Publicado: (2008)

Surgical Strategies for Siewert Type II Esophagogastric Junction Carcinomas: A Randomized Controlled Trial
por: Tao, Kai, et al.
Publicado: (2022)

Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
por: Liang, Rong, et al.
Publicado: (2022)

Availability of Investigational Medicines Through the US Food and Drug Administration’s Expanded Access and Compassionate Use Programs
por: Puthumana, Jeremy, et al.
Publicado: (2018)

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
por: Rizk, John G., et al.
Publicado: (2021)

Characteristics of the Compassionate Use Program in Japan: An Analysis of Expanded Access Clinical Trials from 2016 to 2021
por: Maeda, Hideki, et al.
Publicado: (2022)

Compassionate de-escalation of life-sustaining treatments in pediatric oncology: An opportunity for palliative care and intensive care collaboration
por: Cuviello, Andrea, et al.
Publicado: (2022)

LncRNA BC200 Promotes Esophageal Squamous Cell Cancer Migration and Invasion and Can Regulate ATF4 Expression
por: Zhao, Ruihua, et al.
Publicado: (2020)

Slum compassionate community: expanding access to palliative care in Brazil
por: Mesquita, Maria Gefé da Rosa, et al.
Publicado: (2023)

Upregulation of TIMM8A is correlated with prognosis and immune regulation in BC
por: Zhang, Yu, et al.
Publicado: (2022)

SafeSpace: what is the feasibility and acceptability of a codesigned virtual reality intervention, incorporating compassionate mind training, to support people undergoing cancer treatment in a clinical setting?
por: O'Gara, Geraldine, et al.
Publicado: (2022)

Feasibility and Preliminary Effectiveness of a Tele-Prehabilitation Program in Esophagogastric Cancer Patients
por: Piraux, Elise, et al.
Publicado: (2020)

Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada
por: Attard, C.L., et al.
Publicado: (2010)

Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer
por: Towns, K., et al.
Publicado: (2008)

The compassionate communities connectors program: effect on healthcare usage
por: Aoun, Samar M., et al.
Publicado: (2023)

Targeted Therapies for Metastatic Esophagogastric Cancer
por: Reddy, Deepa, et al.
Publicado: (2011)

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain
por: de la Rubia, Javier, et al.
Publicado: (2023)

Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma
por: Levesque, N., et al.
Publicado: (2008)

Compassionate Counterterrorism
por: Olaimy, Leena
Publicado: (2019)

Compassionate Care
por: Post, Stephen G., et al.
Publicado: (2012)

Compassionate Conversations
por: Gardner, Sharryn, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ff6jne9a69cpg50kfh0m5t4p21